REGISTERED
on 26 Mar 2024
Last Applicant/ Owned by
CH-4105 Biel-Benken
CH
Serial Number
79364303 filed on 12th Jan 2023
Registration Number
7334114 registered on 26th Mar 2024
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
PHARMASENS
Surgical, medical and paramedical apparatus and instruments, namely, medication delivery apparatuses sold without medication, namely, infusion pumps, patch pumps, apparatus for medical use intended for use in diabetes treatment; devices for measuring, monitoring and displaying glucose concentration data in the human body; glucose sensor; parts for medical infusion pumps and patch pumps, namely, re Read More
Classification Information
Class [010]
Medical Instrument Products
Surgical, medical and paramedical apparatus and instruments, namely, medication delivery apparatuses sold without medication, namely, infusion pumps, patch pumps, apparatus for medical use intended for use in diabetes treatment; devices for measuring, monitoring and displaying glucose concentration data in the human body; glucose sensor; parts for medical infusion pumps and patch pumps, namely, receivers, sensor housings, sensor insertion devices and needles
Mark Details
Serial Number
No 79364303
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 1157060576.2
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
Yes
66A Current
Yes
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 26th Mar 2024 | REGISTERED-PRINCIPAL REGISTER |
| 26th Mar 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 09th Jan 2024 | PUBLISHED FOR OPPOSITION |
| 09th Jan 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 08th Jan 2024 | NOTIFICATION PROCESSED BY IB |
| 20th Dec 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 20th Dec 2023 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| 20th Dec 2023 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| 04th Dec 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 04th Nov 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |